Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
EEC 2022
EAN 2022
AHS 2022
CMSC 2022
ESOC 2022
AAN 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Multiple Sclerosis and Related Disorders
2:13
The central vein sign in multiple sclerosis
Pascal Sati
• 26 Feb 2022
2:23
Strategies to target progression in MS
Gavin Giovannoni
• 1 Mar 2022
1:56
The gut microbiome in relapsing versus progressive multiple sclerosis
Daiki Takewaki
• 28 Feb 2022
1:05
The central vein sign: a novel imaging biomarker for MS diagnosis
Pascal Sati
• 26 Feb 2022
1:52
Clinical validation of the MSDA test
Ferhan Qureshi
• 24 Feb 2022
1:00
How does tDCS work in MS?
Leigh Charvet
• 26 Feb 2022
4:05
Latest clinical trials and updates on the relationship between sex hormones and MS
Burcu Zeydan
• 24 Feb 2022
1:22
Targeting remyelination through oligodendrocyte differentiation in MS
Jason Plemel
• 25 Feb 2022
1:41
Socio-scientific issues facing MS treatment in Latin America
Victor Rivera
• 24 Feb 2022
0:50
Cognitive involvement in MS – the importance
Leigh Charvet
• 26 Feb 2022
1:37
An independent focal inflammation cohort – performance of the MSDA validation test algorithm
Ferhan Qureshi
• 24 Feb 2022
1:01
Metformin – a means to promote remyelination in the ageing MS population?
Jason Plemel
• 25 Feb 2022
2:00
Highlights from ACTRIMS: comorbidities & paramagnetic rim lesions in MS
Burcu Zeydan
• 24 Feb 2022
1:21
Focusing on sex and hormones in MS prognosis
Burcu Zeydan
• 24 Feb 2022
1:27
The unmet needs of treating patients with progressive MS
Jason Plemel
• 25 Feb 2022
1:10
The potential of non-invasive brain stimulating therapies in negating the adverse symptoms of MS
Leigh Charvet
• 26 Feb 2022
Previous
1
…
6
7
8
9
10
11
12
13
14
…
29
Next